What is the recommended dosing and duration of amoxicillin‑clavulanate (Augmentin) 1 g twice daily for cellulitis in an adult without a β‑lactam allergy?

Augmentin 1g BD for Cellulitis

For uncomplicated nonpurulent cellulitis in adults, Augmentin (amoxicillin-clavulanate) 1g twice daily is an appropriate choice, and treatment should be given for 5-6 days if clinical improvement occurs, rather than the traditional 10-14 day courses. 1

Dosing Regimen

The standard adult dose of amoxicillin-clavulanate for cellulitis is:

• 1g (875mg amoxicillin/125mg clavulanate) twice daily 2
• Take at the start of meals to minimize gastrointestinal side effects and enhance clavulanate absorption 3

Duration of Therapy

The most recent high-quality evidence supports 5-6 days of treatment:

• The 2021 American College of Physicians guidelines recommend 5-6 days for nonpurulent cellulitis in patients who can self-monitor with close follow-up 1
• The 2014 IDSA guidelines state that 5 days is as effective as 10 days if clinical improvement has occurred 4, 5
• Treatment should be extended only if infection has not improved by day 5 6, 7, 6, 4

This represents a significant shift from older practices. A 2005 guideline noted 5 days equals 10 days in efficacy 8, but the 2021 ACP guidelines provide the most current recommendation prioritizing shorter courses to reduce antimicrobial resistance while maintaining clinical effectiveness.

When Augmentin is Appropriate vs. When to Consider Alternatives

Use Augmentin for nonpurulent cellulitis when:

• Typical presentation: acute redness, warmth, swelling, tenderness
• No purulent drainage or drainable abscess
• No systemic signs of severe infection (SIRS criteria)
• Patient can be managed as outpatient 6, 7, 6, 4

Consider MRSA coverage instead of or in addition to Augmentin if:

• Penetrating trauma (especially injection drug use)
• Purulent drainage present
• Evidence of MRSA infection elsewhere or known nasal colonization
• Systemic toxicity or SIRS present
• Failed initial β-lactam therapy 6, 7, 6, 4

Critical Clinical Pearls

Streptococci are the primary pathogens in typical nonpurulent cellulitis, not MRSA. A prospective study showed 96% success with β-lactams alone (cefazolin/oxacillin), confirming MRSA is uncommon in typical cellulitis 4. This means Augmentin provides appropriate coverage for most cases.

Augmentin provides dual coverage for both streptococci and methicillin-sensitive S. aureus (MSSA), making it broader than necessary for pure cellulitis but reasonable when the distinction from other skin infections is uncertain 9, 8.

Common Pitfalls to Avoid

1. Overtreatment duration: Extending therapy beyond 5-6 days without documented lack of improvement increases side effects and resistance without added benefit 1, 4

2. Unnecessary MRSA coverage: Don't empirically add MRSA coverage (TMP-SMX, doxycycline, clindamycin) for typical nonpurulent cellulitis without risk factors 6, 7, 4

3. Misdiagnosis: Cellulitis mimics (venous stasis dermatitis, contact dermatitis, eczema) don't require antibiotics. Look for acute onset and unilateral presentation 10

4. Missing predisposing factors: Address tinea pedis, toe web maceration, venous insufficiency, or lymphedema to prevent recurrence 4, 5

Monitoring and Follow-up

• Reassess at 72 hours (day 3): If worsening or no improvement, consider MRSA coverage or deeper infection 6, 7, 6
• Complete treatment at 5-6 days if improving 1
• Elevation of affected limb accelerates resolution 4, 5

Hospitalization Criteria

Admit if patient has:

• SIRS criteria (fever, tachycardia, tachypnea, abnormal WBC)
• Altered mental status or hemodynamic instability
• Concern for necrotizing infection or deeper involvement
• Severe immunocompromise
• Failed outpatient therapy 4, 5